Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed a new week for stocks as Wall Street remains on stimulus watch, with Speaker Pelosi setting a 48-hour deadline for reaching an aid deal with the White House. The anchors explored the challenges facing restaurants, airline and movie theaters in wake of the pandemic. On the M&A front, The CEO of ConocoPhillips appeared on the program to discuss...

Carl Quintanilla, David Faber and Leslie Picker discussed today’s stock rally, looking to snap a 3-day losing streak as September retail sales surprise to the upside. Plus shares of Pfizer rally, the drug maker saying it sees an emergency use filing for its COVID-19 vaccine only after the U.S. election. And stimulus stalemate: Speaker Pelosi and Treasury Secretary Mnuchin citing progress in talks...

Carl Quintanilla, Jim Cramer and David Faber discussed a rough morning for stocks As worries about an impasse in the stimulus talks and worries about a coronavirus "2nd Wave" spark a sell-off on Wall Street. They also explored what the negative market sentiment would mean for this year's high-flying stocks including Zoom Media, Peloton and Fastly. Bank earnings also on the front burner, including...

Carl Quintanilla, Jim Cramer and David Faber discussed another big day of bank earnings, with Bank of America, Goldman Sachs and Wells posting results before the beginning of trading -- as stocks look to rebound after snapping a four-day win streak. COVID-19 also in focus with Eli Lilly becoming the latest drug maker to pause its trial of a coronavirus antibody-based treatment. Carl, Jim and David...

As stocks entered the morning with a four-day win streak, Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the markets with earnings season getting underway. The anchors took an in-depth look at better-than-expected results from JPMorgan Chase and Citigroup as well as the challenges facing both banks. Plus, Johnson & Johnson's earnings were overshadowed by the company pausin...

Carl Quintanilla, Jim Cramer and David Faber discussed the upward momentum for stocks as we begin a new trading week. The anchors previewed what to expect from this week's bank earnings, with the first results due out Tuesday. They also took a closer look at the stimulus stalemate as talks between Capitol Hill Democrats and the White House on COVID-19 aid relief reach an impasse. Also on the coron...

Carl Quintanilla, Jim Cramer and David Faber discussed the big corporate story of the day: Chipmaker AMD reportedly in advance talks to buy Xilinx in a deal that could be worth more than $30-billion. The anchors explored what such a transaction could mean for the semiconductor sector and where China fits into the mix. Markets also paying close attention to Speaker Pelosi, Treasury Secretary Mnuchi...

Carl Quintanilla, Jim Cramer and David Faber discussed an upbeat morning for stocks, rising on hopes Congress will approve a stimulus package -- with President Trump saying that aid talks are beginning to work out. News on coronavirus treatments also adding to positive sentiment: Regeneron and Lilly shares among the gainers as both companies have requested that the FDA authorize their COVID-19 ant...

Carl Quintanilla, Jim Cramer and David Faber discussed the big rebound in stocks after President Trump tweeted that he would approve a series of coronavirus relief measures -- a change from Tuesday when stocks fell sharply after the president tweeted the White House would halt stimulus talks with Democrats. The anchors took an in-depth look at the airline industry as it hopes to benefit from a sta...

With the Dow coming off its best day since July, Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks as Wall Street pays close attention to COVID-19, President Trump's health, and the push for treatments and vaccines. The anchors react to the president removing his mask upon returning to the White House from the hospital Monday night, as well as what Democratic preside...

Carl Quintanilla, Jim Cramer and David Faber focused on stocks' positive start to a new week of trading, Wall Street hoping that President Trump is recovering from COVID-19 and that the stimulus talks will result in Congress passing a relief bill. They also discussed the CEO of Regeneron telling CNBC that he hopes the company's antibody cocktail will help President Trump recover from COVID-19. The...

Carl Quintanilla, Jim Cramer and David Faber focused on the big story of the day: President Trump testing positive for COVID-19 and the market's negative reaction to that news. They discussed its impact on the road ahead for stocks, the stimulus talks, reopening plans across the nation, the presidential election and the Supreme Court nomination schedule. Also in the spotlight: The Labor Department...

Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the stock markets in the 4th quarter after coming off their best quarter since 2017. This as Wall Street pays close attention to the stimulus talks in Washington, with airlines announcing furloughs since Congress has yet to strike a deal on a COVID-relief package. The anchors also took a closer look at Palantir one day after i...

Carl Quintanilla, Jim Cramer and David Faber discussed market reaction to Tuesday night's presidential debate and what's at stake for stocks. That was followed by CNBC and Institutional Investor's "Delivering Alpha" conference: Becky Quick conducted a live interview with Treasury Secretary Steven Mnuchin about the economy and the COVID-19 stimulus talks. Carl, Jim and David offered their reactions...

Carl Quintanilla, Jim Cramer and David Faber discussed in-depth the COVID-19 stimulus talks and the Democrats' new $2.2-trillion coronavirus aid package and how the impasse in the talks has taken a toll on businesses such as restaurants and the push to revive the economy. They also explored the road ahead for stocks after Monday's rally. M&A also in the spotlight, with LVMH countersuing to Tiffany...

Carl Quintanilla, Kelly Evans & Mike Santoli discuss the Monday rally for stocks, building on Friday’s sharp gains as the Dow and S&P look to snap their first 4-week losing streak of 2020. Plus signs for stimulus optimism, Speaker Pelosi saying there’s a chance for a deal with Treasury Secretary and the White House. And a pause for TikTok, why a U.S. judge sided with Bytedance and block the Trump...

Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, d...

Jim Cramer and David Faber discuss the September slump for stocks, volatility continuing as wall street seeks to recover from the worst sell-off in 2 weeks. Goldman Sachs cuts its Q4 GDP outlook amid diminished hopes for a DC stimulus deal. Plus wild swings for shares Nikola continuing, the electric truck maker downgraded to sell at Wedbush. And United Airlines becoming the first major U.S. airlin...

Carl Quintanilla, Jim Cramer and David Faber discussed news out of Johnson & Johnson. The company's COVID-19 vaccine candidate has entered late-stage testing. They also weighed in on the rally in Nike shares after the company's quarterly results blew past street expectations. Tesla also in focus with shares falling after Tuesday's much-anticipated "Battery Day" as Wall Street analysts had mixed re...

Carl Quintanilla, Jim Cramer and David Faber discussed what's next for the markets after Monday's sell-off, especially when ot comes to high-profile stocks that have recently taken a hit. They also previewed what to expect from Tesla's "Battery Day" which gets underway after the close of trading today. The impact of COVID-19 also in focus, from the UK Prime Minister announcing new restrictions in...

Carl Quintanilla, Jim Cramer and David Faber discuss the September stock slump: stalled stimulus talks, lockdown warnings in the U.K. and growing global virus fears as the Wall Street selloff extends 3-weeks and counting. Plus the TikTok deal with Oracle & Walmart gets the blessing from President Trump, sort of… but big questions remain. And shares of electric truck maker Nikola tumbling as the co...

Carl Quintanilla, Jim Cramer and David Faber discuss the latest in the TikTok saga, as the Commerce Department announces that the administration will block downloads of both WeChat & TikTok on Sunday. Plus Wall Street looking for its first weekly gain of the month, seeking to rebound from another sharp tech sell-off in technology stocks. And the race to treat COVID-19, Roche unveiling a new antibo...

Carl Quintanilla, Jim Cramer and David Faber discuss Snowflake’s big debut, the largest software IPO ever with more software IPOs on tap this week & why buyers might want to beware. Tech stocks sell-off again, with Apple among the biggest lagards, why Jim thinks it’s not a 1999 redux. Plus David’s latest reporting on LVMH & and the Tiffany merger legal battle. Airline executives make the case for...

Carl Quintanilla, Jim Cramer and David Faber discuss the boost for stocks. The Dow, S&P 500 aim for its fourth straight day of gains. A positive sign on the COVID-19 front, Eli Lilly reporting a reduced rate of hospitalizations for its coronavirus patients using its antibody treatment. Plus, it’s the largest ever software IPO, Snowflake pricing above the increased range in an offering valuing the...

Carl Quintanilla, Jim Cramer and David Faber discuss the surge for stocks, building on Monday’s gains on the back of the tech reversal and solid economic data. Shares of Nikola getting hammered as investors respond to news that the SEC is going to be examining the company over short seller allegations. The CEO of Lowe’s, Marvin Ellison, joining “Squawk on the Street” to discuss a new initiative fo...